Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DVA

DaVita Inc

Dec 07 • 02:20PM ET

105.32

Dollar change +1.16
Percentage change 1.11	%

Healthcare • Medical Care Facilities • USA • NYSE

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	S&P 500	P/E	16.51	EPS (ttm)	6.38	Insider Own	1.07%	Shs Outstand	90.41M	Perf Week	3.80%
Market Cap	9.62B	Forward P/E	12.38	EPS next Y	8.51	Insider Trans	-0.99%	Shs Float	90.33M	Perf Month	31.50%
Income	595.52M	PEG	0.90	EPS next Q	1.61	Inst Own	89.59%	Short Float / Ratio	7.45% / 4.97	Perf Quarter	10.22%
Sales	11.91B	P/S	0.81	EPS this Y	17.52%	Inst Trans	-2.61%	Short Interest	6.73M	Perf Half Y	5.23%
Book/sh	13.13	P/B	8.02	EPS next Y	9.65%	ROA	3.51%	Target Price	104.43	Perf Year	42.65%
Cash/sh	6.10	P/C	17.27	EPS next 5Y	18.27%	ROE	68.77%	52W Range	70.80 - 116.97	Perf YTD	41.05%
Dividend	-	P/FCF	7.29	EPS past 5Y	10.46%	ROI	5.04%	52W High	-9.96%	Beta	1.01
Dividend %	-	Quick Ratio	1.19	Sales past 5Y	1.33%	Gross Margin	24.32%	52W Low	48.76%	ATR	2.80
Employees	70000	Current Ratio	1.24	Sales Q/Q	5.85%	Oper. Margin	12.13%	RSI (14)	74.38	Volatility	2.91% 3.13%
Optionable	Yes	Debt/Eq	9.28	EPS Q/Q	132.13%	Profit Margin	5.00%	Rel Volume	0.36	Prev Close	104.16
Shortable	Yes	LT Debt/Eq	8.86	Earnings	Nov 07 AMC	Payout	0.00%	Avg Volume	1.35M	Price	105.32
Recom	2.78	SMA20	9.05%	SMA50	19.33%	SMA200	13.77%	Volume	368,494	Change	1.11%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-07-23	Upgrade	UBS	Neutral → Buy	$100 → $142
Nov-01-22	Downgrade	Deutsche Bank	Buy → Hold	$97 → $72
Oct-31-22	Downgrade	UBS	Buy → Neutral	$117 → $74
Aug-19-22	Resumed	UBS	Buy	$106 → $117
Jun-21-22	Reiterated	BofA Securities	Underperform	$110 → $90
Sep-10-21	Initiated	Cowen	Market Perform	$145
Aug-12-21	Downgrade	Barclays	Overweight → Equal Weight	$135 → $146
Mar-26-21	Downgrade	BofA Securities	Neutral → Underperform	$127 → $118
Jan-05-21	Downgrade	BofA Securities	Buy → Neutral	$127
Jan-24-20	Upgrade	Goldman	Neutral → Buy	$72 → $97
Nov-07-19	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-25-19	Downgrade	Wolfe Research	Outperform → Peer Perform
Sep-11-19	Downgrade	William Blair	Outperform → Mkt Perform
Jul-26-19	Downgrade	Robert W. Baird	Outperform → Neutral	$70 → $65
Jan-08-19	Upgrade	UBS	Sell → Neutral
Jan-03-19	Initiated	Deutsche Bank	Buy	$60
Dec-14-18	Initiated	Barclays	Overweight
Nov-28-18	Upgrade	Raymond James	Mkt Perform → Outperform
Nov-16-18	Initiated	UBS	Sell	$64
Nov-08-18	Downgrade	Raymond James	Strong Buy → Mkt Perform

Show Previous Ratings

Today 11:31AM	DaVita HealthCare (DVA) Up 22.8% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-30-23 10:00AM	DaVita's 'Move It With Purpose' Event Achieves Record-Breaking Participation to Support Life-Saving Care (PR Newswire)
Nov-28-23 06:30AM	'Things were way tougher': Charlie Munger's blunt message to whiners worried about 'hardship' plus 3 stocks Warren Buffett's right-hand man uses to supercharge his finances (Moneywise)
04:03AM	Warren Buffett Sees Big Gains in These Small-Cap Stocks (Insider Monkey)
Nov-27-23 11:20AM	11 Best Stocks to Buy for Good Returns (Insider Monkey)
09:07AM	Loading…
09:07AM	11 Best Performing Warren Buffett Stocks in 2023 (Insider Monkey)
Nov-22-23 10:40AM	Why You Should Add DaVita (DVA) Stock to Your Portfolio (Zacks)
09:40AM	Should Value Investors Buy DaVita (DVA) Stock? (Zacks)
Nov-15-23 11:54PM	Analyst Report: DaVita Inc. (Morningstar Research)
Nov-13-23 09:31AM	Novo Nordisk's Wegovy could reduce heart risks in new trial (Yahoo Finance Video) +6.49%
Nov-10-23 12:00PM	All You Need to Know About DaVita HealthCare (DVA) Rating Upgrade to Strong Buy (Zacks)
Nov-09-23 09:55AM	Does DaVita HealthCare (DVA) Have the Potential to Rally 33.24% as Wall Street Analysts Expect? (Zacks)
Nov-08-23 05:46PM	DaVita Inc. (NYSE:DVA) Q3 2023 Earnings Call Transcript (Insider Monkey) +5.89%
12:22PM	Roblox, DaVita rise; Toast, Lucid Group fall, Wednesday, 11/8/2023 (Associated Press)
10:56AM	DaVita (DVA) Q3 Earnings & Revenues Top Estimates, Margins Up (Zacks)
07:27AM	Loading…
07:27AM	Q3 2023 DaVita Inc Earnings Call (Thomson Reuters StreetEvents)
01:33AM	Q3 2023 Nuwellis Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-07-23 10:07PM	Analyst Report: DaVita Inc. (Morningstar Research)
08:30PM	DaVita (DVA) Q3 2023 Earnings Call Transcript (Motley Fool)
04:44PM	DaVita Inc. (DVA) Reports Solid Earnings Growth and Robust Cash Flow in Q3 2023 (GuruFocus.com)
04:40PM	DaVita HealthCare: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	DaVita Inc. 3rd Quarter 2023 Results (PR Newswire)
09:40AM	Here's Why DaVita HealthCare (DVA) is a Strong Value Stock (Zacks)
Nov-06-23 09:40AM	Are Investors Undervaluing DaVita (DVA) Right Now? (Zacks)
Nov-03-23 12:21PM	DaVita (DVA) to Report Q3 Earnings: What's in the Offing? (Zacks)
Nov-02-23 12:05PM	DaVita Unveils New Research to Drive Health Equity and Improve Care Quality during Annual American Society of Nephrology Meeting (PR Newswire)
Oct-25-23 12:33PM	NextGen (NXGN) Q2 Earnings Top Estimates, Margins Down (Zacks)
Oct-24-23 07:00AM	Buffetts Bullish Bets: 3 Stocks Where Warren Has At Least a 25% Stake (InvestorPlace)
Oct-23-23 10:15AM	DaVita's (DVA) Latest Partnership to Improve Kidney Care (Zacks)
09:40AM	Is AVROBIO (AVRO) Outperforming Other Medical Stocks This Year? (Zacks)
08:00AM	Loading…
08:00AM	3 Stocks to Buy From the Buy the Dip ETF (InvestorPlace)
Oct-20-23 09:40AM	Is DaVita (DVA) Stock Undervalued Right Now? (Zacks) -5.02%
Oct-18-23 04:52PM	S&P 500 Gains and Losses Today: Airline Stocks Fall Amid Canceled Flights, Fuel Costs (Investopedia)
12:00PM	DaVita Collaborates with Google Cloud to Develop Customized Clinical Operating System Designed to Transform Kidney Care (PR Newswire)
11:10AM	Quest Diagnostics (DGX) Gains From New Alliances Amid FX Woes (Zacks)
11:05AM	Align (ALGN) Gains From New Launches, Strategic Partnerships (Zacks)
10:59AM	Here's Why You Should Retain QIAGEN (QGEN) Stock for Now (Zacks)
10:10AM	Here's Why You Should Add DaVita (DVA) Stock to Your Portfolio (Zacks)
Oct-17-23 06:26PM	DaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call (PR Newswire)
11:34AM	Is DaVita (DVA) Too Good to Be True? A Comprehensive Analysis of a Potential Value Trap (GuruFocus.com)
10:08AM	PetMeds (PETS) to Advance Pet Care With New Collaboration (Zacks)
Oct-16-23 10:39AM	Here's Why You Should Invest in Insulet (PODD) Stock for Now (Zacks)
10:38AM	Alcon (ALC) Stock Up 9.7% YTD: Will the Rally Continue? (Zacks)
Oct-13-23 12:41PM	Teleflex (TFX) Advances Urology Portfolio With New Buyout (Zacks)
Oct-12-23 12:55PM	UPDATE 1-Fresenius Medical: effect of drugs like Ozempic on patient numbers is neutral (Reuters)
11:07AM	Walgreens Boots (WBA) Q4 Earnings Miss Estimates, Margins Down (Zacks)
11:03AM	Here's Why You Should Hold on to Penumbra (PEN) Stock for Now (Zacks)
08:47AM	UPDATE 2-DaVita sees limited impact from Ozempic's kidney trial success (Reuters)
08:37AM	DaVita says Ozempic's early success in kidney trial to have 'limited application' (Reuters)
08:30AM	DaVita Statement on GLP-1 and Potential Implications on Chronic Kidney Disease (PR Newswire)
Oct-11-23 03:57PM	Ozempic Kidney Trial Sinks Dialysis Stocks (The Wall Street Journal) -16.86%
01:01PM	Analyst Report: DaVita Inc. (Morningstar Research)
12:43PM	Neogen's (NEOG) Q1 Earnings Miss Estimates, Margins Rise (Zacks)
12:28PM	Ozempic Alert: New Trial Causes DaVita (DVA) Stock to Plunge 20% (InvestorPlace)
12:17PM	Voxx International, Walgreens rise; Exxon Mobil, DaVita fall, Wednesday, 10/11/2023 (AP Finance)
11:52AM	What's Going On With Kidney Dialysis Provider Stocks Today? (Benzinga)
11:33AM	DaVita (DVA): A Smart Investment or a Value Trap? An In-Depth Exploration (GuruFocus.com)
11:25AM	Novo Nordisk stock pops on Ozempic kidney trial success (Yahoo Finance Video)
10:47AM	Here's Why You Should Invest in Boston Scientific (BSX) Now (Zacks)
10:45AM	Dialysis Providers Are the Top Decliners in the S&P 500 Wednesday (Barrons.com)
10:22AM	Novo Nordisk Halts Ozempic Kidney Trial. Why Its Bad for DaVita Stock. (Barrons.com)
10:04AM	Alcon (ALC) Expands Optical Care Line With Latest Launch (Zacks)
09:40AM	Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term (Zacks)
06:02AM	Ozempic's early success in kidney disease trial drags on dialysis stocks (Reuters)
Oct-10-23 12:03PM	Unveiling DaVita Inc (DVA)'s Market Leadership: A Deep Dive into Its Financial Growth and ... (GuruFocus.com)
11:57AM	Masimo's (MASI) LiDCO to Boost Hemodynamic Monitoring Post CE Mark (Zacks)
11:28AM	3 Reasons to Add Surmodics (SRDX) Stock to Your Portfolio (Zacks)
10:10AM	Thermo Fisher's (TMO) Strong End Markets and New Buyouts Aid (Zacks)
10:02AM	Hyperfine (HYPR) Progresses in MRI Space With Latest FDA Nod (Zacks)
09:40AM	Are Investors Undervaluing Addus HomeCare (ADUS) Right Now? (Zacks)
09:10AM	Here's Why You Should Retain Charles River (CRL) Stock Now (Zacks)
Oct-09-23 11:15AM	ResMed (RMD) Gains From Strong Device Sales Amid Macro Woes (Zacks)
11:15AM	3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio (Zacks)
11:08AM	enVVeno (NVNO) Plans to Expedite enVVe Development for CVI (Zacks)
10:47AM	Veradigm (MDRX)-FDB Vela to Enhance Pharmacy Connectivity (Zacks)
09:58AM	Here's Why You Should Retain Teleflex (TFX) Stock for Now (Zacks)
Oct-06-23 12:11PM	Three Reasons to Add PacBio (PACB) Stock to Your Portfolio (Zacks)
12:03PM	OPKO Health (OPK) Gets BARDA Contract to Combat Antibody Threats (Zacks)
11:33AM	Quest Diagnostics (DGX) to Boost Lab Services With New Pact (Zacks)
Oct-05-23 11:05AM	3 Reasons to Add Merit Medical (MMSI) Stock to Your Portfolio (Zacks)
10:45AM	AngioDynamics (ANGO) Q1 Earnings and Revenues Top Estimates (Zacks)
10:09AM	Here's Why You Should Buy Globus Medical (GMED) Stock Now (Zacks)
10:08AM	LabCorp (LH) to Expand Diagnostics Services With New Deal (Zacks)
Oct-04-23 12:32PM	Veradigm (MDRX) Advances Tie-Up to Enhance Care Delivery (Zacks)
11:40AM	DVA vs. CHE: Which Stock Is the Better Value Option? (Zacks)
11:29AM	Here's Why You Should Invest in Neogen (NEOG) Stock Now (Zacks)
11:27AM	Medtronic (MDT) to Launch Academic R&D Grants With New Pact (Zacks)
10:17AM	Warren Buffett and Ken Griffin Have One Thing in Common: Theyre Making a Big Bet on These 3 Stocks (TipRanks)
Oct-03-23 11:21AM	Accuray's (ARAY) New Offering to Boost Radiation Treatment Plans (Zacks)
Oct-02-23 09:40AM	Should Value Investors Buy Quest Diagnostics (DGX) Stock? (Zacks)
Sep-29-23 07:20PM	Analyst Report: DaVita Inc. (Morningstar Research)
12:20PM	Here's Why You Should Retain Zimmer Biomet (ZBH) for Now (Zacks)
10:15AM	Veradigm's (MDRX) New Tie-Up to Boost Patients' Health Outcomes (Zacks)
Sep-28-23 08:26PM	Top Medical Stocks to Buy Amid Market Volatility (Zacks)
12:01PM	Here's Why You Should Retain Ecolab (ECL) Stock for Now (Zacks)
09:49AM	Here's Why You Should Retain Medtronic (MDT) Stock for Now (Zacks)
Sep-27-23 06:46PM	Buy These 3 Low-Beta Stocks to Navigate Volatility (Zacks)
10:59AM	3 Reasons to Hold Catalent (CTLT) Stock in Your Portfolio (Zacks)
09:55AM	Here's Why You Should Invest in Penumbra (PEN) Stock for Now (Zacks)
09:37AM	Here's Why Investors Should Retain Omnicell (OMCL) Stock Now (Zacks)

DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Aug 22	Option Exercise	52.41	40,000	2,096,400	121,297	Aug 24 06:54 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	Aug 22	Sale	101.81	9,794	997,099	81,297	Aug 24 06:54 PM
YALE PHYLLIS R	Director	May 12	Option Exercise	66.29	7,165	474,968	20,275	May 12 09:31 PM
YALE PHYLLIS R	Director	May 12	Sale	95.26	2,196	209,195	13,110	May 12 09:31 PM
STAFFIERI MICHAEL DAVID	Chief Operating Officer, DKC	May 10	Option Exercise	66.29	243,994	16,174,362	348,071	May 12 09:34 PM
Rodriguez Javier	Chief Executive Officer	May 10	Option Exercise	66.29	88,213	5,847,640	403,835	May 12 09:20 PM
ACKERMAN JOEL	CFO and Treasuer	May 10	Option Exercise	66.29	56,306	3,732,525	191,097	May 12 08:44 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	May 10	Option Exercise	66.29	33,784	2,239,541	135,164	May 12 09:15 PM
HEARTY JAMES O	Chief Compliance Officer	May 10	Option Exercise	66.29	26,276	1,741,836	58,835	May 12 08:48 PM
DESOER BARBARA J	Director	May 10	Option Exercise	66.29	7,165	474,968	7,165	May 12 08:46 PM
NEHRA JOHN M	Director	May 10	Option Exercise	66.29	7,165	474,968	7,165	May 12 08:50 PM
Rodriguez Javier	Chief Executive Officer	May 10	Sale	99.44	16,916	1,682,089	315,622	May 12 09:20 PM
Waters Kathleen Alyce	Chief Legal & Pub. Affairs Off	May 10	Sale	99.24	15,941	1,581,990	91,245	May 12 09:15 PM
HEARTY JAMES O	Chief Compliance Officer	May 10	Sale	101.64	5,745	583,914	32,559	May 12 08:48 PM
DESOER BARBARA J	Director	May 10	Sale	101.61	2,449	248,843	0	May 12 08:46 PM
BERG CHARLES	Director	Mar 09	Sale	75.13	1,431	107,513	15,733	Mar 13 06:04 PM
BERG CHARLES	Director	Mar 01	Sale	81.78	735	60,108	17,164	Mar 02 05:42 PM
BERG CHARLES	Director	Feb 28	Option Exercise	66.29	7,165	474,968	23,633	Mar 02 05:42 PM
BERG CHARLES	Director	Feb 24	Option Exercise	65.94	3,601	237,450	19,334	Feb 27 06:18 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DVA

DaVita Inc

Upgrade your FINVIZ experience